Target Healthcare REIT (LON:THRL) Stock Rating Reaffirmed as Buy by Jefferies Financial Group

Target Healthcare REIT (LON:THRL)‘s stock had its “buy” rating reissued by Jefferies Financial Group in a note issued to investors on Wednesday, Digital Look reports. They presently have a GBX 124 target price on the stock. Jefferies Financial Group‘s price objective would suggest a potential upside of 3.16% from the stock’s current price.

Target Healthcare REIT Price Performance

THRL stock opened at GBX 120.20 on Wednesday. Target Healthcare REIT has a one year low of GBX 92 and a one year high of GBX 120.60. The stock has a market cap of £745.52 million, a PE ratio of 9.02, a P/E/G ratio of 1.48 and a beta of 0.71. The firm has a 50 day simple moving average of GBX 113.17 and a two-hundred day simple moving average of GBX 108.36.

Target Healthcare REIT (LON:THRL) last issued its quarterly earnings results on Wednesday, September 23rd. The company reported GBX 13.32 EPS for the quarter. Target Healthcare REIT had a net margin of 114.60% and a return on equity of 11.03%. On average, research analysts expect that Target Healthcare REIT will post 6.22 EPS for the current fiscal year.

Target Healthcare REIT Company Profile

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.